To further validate the clinical significance of CDK11p110 expression in patients with breast cancer, we detected CDK11p110 levels in a breast tumor tissue microarray by immunohistochemistry, and evaluated the correlation of CDK11p110 expression to the pathological characteristics and clinical prognosis of breast cancer patients. The gene discussed is CDK11A; the disease is breast carcinoma.